Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers

References

• YouldenDRCrambSMDunnNAMullerJMPykeCMBaadePDThe descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortalityCancer Epidemiol201236323724822459198
   PubMed Web of Science ®Google Scholar
• WeiTLiuJMaHFunctionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivoNano Lett20131362528253423634882
   PubMed Web of Science ®Google Scholar
• RenYWangYZhangYWeiDOvercoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide doxorubicin conjugate in vitro and in vivoMol Pharm20085457958718461970
   PubMedGoogle Scholar
• WangFWangYCDouSXiongMHSunTMWangJDoxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cellsACS Nano2011553679369221462992
   PubMed Web of Science ®Google Scholar
• LiuJMaHWeiTLiangXJCO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cellsChem Comm (Camb)2012484048694871
   PubMed Web of Science ®Google Scholar
• KlappeKHummelIHoekstraDKokJWLipid dependence of ABC transporter localization and functionChem Phys Lipids20091612576419651114
   PubMed Web of Science ®Google Scholar
• BaoYYinMHuXA safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting deliveryJ Control Release201623518219427264552
   PubMed Web of Science ®Google Scholar
• JiangLLiLHeXOvercoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-responseBiomaterials20155212613925818419
   PubMed Web of Science ®Google Scholar
• WangMThanouMTargeting nanoparticles to cancerPharm Res20072411029104617385025
   PubMedGoogle Scholar
• HwangMHLimJHYunHISurfactin C inhibits the lipopolysaccharide-induced transcription of interleukin-1β and inducible nitric oxide synthase and nitric oxide production in murine RAW 264.7 cellsBiotechnol Lett200527201605160816245181
   PubMed Web of Science ®Google Scholar
• LeeMHLeeJNamYDLeeJSSeoMJYiSHCharacterization of antimicrobial lipopeptides produced by Bacillus sp.LM7 isolated from chungkookjang, a Korean traditional fermented soybean foodInt J Food Microbiol2016221121826803269
   PubMed Web of Science ®Google Scholar
• LoiseauCSchlusselhuberMBigotRBertauxJBerjeaudJMVerdonJSurfactin from Bacillus subtilis displays an unexpected anti-Legionella activityAppl Microbiol Biotechnol201599125083509325573468
   PubMed Web of Science ®Google Scholar
• KrachtMRokosHOzelMKowallMPauliGVaterJAntiviral and hemolytic activities of surfactin isoforms and their methyl ester derivativesJ Antibiot (Tokyo)199952761361910513840
   PubMed Web of Science ®Google Scholar
• ZhangYLiuCDongBAnti-inflammatory activity and mechanism of surfactin in lipopolysaccharide-activated macrophagesInflammation201538275676425331175
   PubMed Web of Science ®Google Scholar
• GanPJinDZhaoXBacillus-produced surfactin attenuates chronic inflammation in atherosclerotic lesions of ApoE(−/−) miceInt Immunopharmacol20163522623427082998
   PubMed Web of Science ®Google Scholar
• KimSYKimJYKimSHSurfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppressionFEBS Lett2007581586587117292358
   PubMed Web of Science ®Google Scholar
• VollenbroichDOzelMVaterJKampRMPauliGMechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilisBiologicals19972532892979324997
   PubMed Web of Science ®Google Scholar
• CaoXHZhaoSSLiuDYROS-Ca2+ is associated with mitochondria permeability transition pore involved in surfactin-induced MCF-7 cells apoptosisChem Biol Interact20111901162721241685
   PubMed Web of Science ®Google Scholar
• CaoXHLiaoZYWangCLYangWYLuMFEvaluation of a lipopeptide biosurfactant from Bacillus natto TK-1 as a potential source of anti-adhesive, antimicrobial and antitumor activitiesBraz J Microbiol200940237337924031375
   PubMed Web of Science ®Google Scholar
• CaoXHLiaoZYWangCLPurification and antitumour activity of a lipopeptide biosurfactant produced by Bacillus natto TK-1Appl Biochem200952Pt 297106
   Google Scholar
• ChristovaNTulevaBKrilAChemical structure and in vitro antitumor activity of rhamnolipids from Pseudomonas aeruginosa BN10Appl Biochem Biotechnol2013170367668923604971
   PubMed Web of Science ®Google Scholar
• CaoXHWangAHWangCLSurfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathwayChem Biol Interact2010183335736219954742
   PubMed Web of Science ®Google Scholar
• StrausSKHancockREMode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptidesBiochim Biophys Acta2006175891215122316615993
   PubMed Web of Science ®Google Scholar
• YangHWangQHuangSSmart pH/redox dual-responsive nanogels for on-demand intracellular anticancer drug releaseACS Appl Mater Interfaces20168127729773826960600
   PubMed Web of Science ®Google Scholar
• XiaoLXiongXSunXRole of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micellesBiomaterials201132225148515721546083
   PubMed Web of Science ®Google Scholar
• ZhangHLiangCHouXWangLZhangDStudy of the combined treatment of lung cancer using gene-loaded immunomagnetic albumin nanospheres in vitro and in vivoInt J Nanomedicine2016111039105027042059
   PubMed Web of Science ®Google Scholar
• LianHWuJHuYGuoHSelf-assembled albumin nanoparticles for combination therapy in prostate cancerInt J Nanomedicine20171217777778729123392
   PubMedGoogle Scholar
• LiuJLiQZhangJSafe and effective reversal of cancer multidrug resistance using sericin-coated mesoporous silica nanoparticles for lysosome-targeting delivery in miceSmall20171391602567
   Web of Science ®Google Scholar
• GuptaBRamasamyTPoudelBKDevelopment of bioactive PEGylated nanostructured platforms for sequential delivery of doxorubicin and imatinib to overcome drug resistance in metastatic tumorsACS Appl Mater Interfaces20179119280929028240860
   PubMed Web of Science ®Google Scholar